Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Femasys Inc. (FEMY)

Compare
1.2300
-0.0600
(-4.65%)
At close: April 3 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,629.1080
1,629.1080
1,071.9700
1,206.2180
1,179.6890
Cost of Revenue
544.9030
544.9030
380.0690
441.9380
370.3840
Gross Profit
1,084.2050
1,084.2050
691.9010
764.2800
809.3050
Operating Expense
18,870.0100
18,870.0100
15,200.3160
12,364.5440
9,146.1090
Operating Income
-17,785.8050
-17,785.8050
-14,508.4150
-11,600.2640
-8,336.8040
Net Non Operating Interest Income Expense
-1,021.2210
-1,021.2210
265.6290
214.7000
-15.4580
Other Income Expense
--
--
--
-2.3060
818.4170
Pretax Income
-18,807.0260
-18,807.0260
-14,242.7860
-11,387.8700
-7,533.8450
Tax Provision
9.6020
9.6020
4.3380
6.3000
4
Net Income Common Stockholders
-18,816.6280
-18,816.6280
-14,247.1240
-11,394.1700
-7,537.8450
Diluted NI Available to Com Stockholders
-18,816.6280
-18,816.6280
-14,247.1240
-11,394.1700
-7,537.8450
Basic EPS
-0.85
--
-0.93
-0.96
-1.12
Diluted EPS
-0.85
--
-0.93
-0.96
-1.12
Basic Average Shares
22,267.6950
--
15,384.3760
11,815.0190
6,712.0280
Diluted Average Shares
22,267.6950
--
15,384.3760
11,815.0190
6,712.0280
Total Operating Income as Reported
-17,785.8050
-17,785.8050
-14,508.4150
-11,600.2640
-8,336.8040
Total Expenses
19,414.9130
19,414.9130
15,580.3850
12,806.4820
9,516.4930
Net Income from Continuing & Discontinued Operation
-18,816.6280
-18,816.6280
-14,247.1240
-11,394.1700
-7,537.8450
Normalized Income
-18,816.6280
-18,816.6280
-14,247.1240
-11,394.1700
-7,537.8450
Interest Income
582.3540
582.3540
431.0190
228.1640
3.7680
Interest Expense
1,603.5750
1,603.5750
165.3900
13.4640
19.2260
Net Interest Income
-1,021.2210
-1,021.2210
265.6290
214.7000
-15.4580
EBIT
-17,203.4510
-17,203.4510
-14,077.3960
-11,374.4060
-7,514.6190
EBITDA
-16,331.4510
-16,331.4510
-13,169.4110
-10,485.2660
-6,550.3320
Reconciled Cost of Revenue
544.9030
544.9030
380.0690
114.0310
370.3840
Reconciled Depreciation
872
872
907.9850
889.1400
964.2870
Net Income from Continuing Operation Net Minority Interest
-18,816.6280
-18,816.6280
-14,247.1240
-11,394.1700
-7,537.8450
Normalized EBITDA
-16,331.4510
-16,331.4510
-13,169.4110
-10,485.2660
-6,550.3320
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 6/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SMTI Sanara MedTech Inc.
29.40
-2.23%
 
GCTK GlucoTrack, Inc.
0.1870
-6.59%
 
BLFS BioLife Solutions, Inc.
22.44
-5.63%
 
POAI Predictive Oncology Inc.
1.3700
-2.14%
 
STXS Stereotaxis, Inc.
1.6700
-4.57%
 
NYXH Nyxoah S.A.
6.99
+7.54%
 
KRMD KORU Medical Systems, Inc.
2.3600
-7.45%
 
NEPH Nephros, Inc.
2.1300
+4.93%
 
NXGL NEXGEL, Inc.
2.6700
-6.32%
 
AKYA Akoya Biosciences, Inc.
1.2200
-10.29%